• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用F-2-氟脱氧葡萄糖(FDG)标记抗体片段用于胰腺癌的免疫正电子发射断层显像(immuno-PET)。

The use of F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.

作者信息

Rashidian Mohammad, Keliher Edmund, Dougan Michael, Juras Patrick K, Cavallari Marco, Wojtkiewicz Gregory R, Jacobsen Johanne, Edens Jerre G, Tas Jeroen M G, Victora Gabriel, Weissleder Ralph, Ploegh Hidde

机构信息

Whitehead Institute for Biomedical Research, Cambridge, MA 02142; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142.

Center for Systems Biology Department, Massachusetts General Hospital, 185 Cambridge St., Boston, MA 02114 (USA).

出版信息

ACS Cent Sci. 2015 Jun 24;1(3):142-147. doi: 10.1021/acscentsci.5b00121. Epub 2015 Jun 3.

DOI:10.1021/acscentsci.5b00121
PMID:26955657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4778250/
Abstract

We generated F-labeled antibody fragments for PET imaging using a sortase-mediated reaction to install a transcyclooctene (TCO)-functionalized short peptide onto proteins of interest, followed by reaction with a tetrazine-labeled-F-2-deoxyfluoroglucose (FDG). The method is rapid, robust, and site-specific (radiochemical yields >25%, not decay corrected). The availability of F-2-deoxyfluoroglucose avoids the need for more complicated chemistries used to generate carbon-fluorine bonds. We demonstrate the utility of the method by detecting heterotopic pancreatic tumors in mice by PET, using anti-Class II MHC single domain antibodies. We correlate macroscopic PET images with microscopic two-photon visualization of the tumor. Our approach provides easy access to F-labeled antibodies and their fragments at a level of molecular specificity that complements conventionalF-FDG imaging.

摘要

我们使用分选酶介导的反应生成用于正电子发射断层扫描(PET)成像的F标记抗体片段,即将反式环辛烯(TCO)功能化的短肽安装到感兴趣的蛋白质上,然后与四嗪标记的F-2-脱氧氟葡萄糖(FDG)反应。该方法快速、稳健且具有位点特异性(放射化学产率>25%,未进行衰变校正)。F-2-脱氧氟葡萄糖的可用性避免了使用更复杂的化学方法来生成碳-氟键的需求。我们通过使用抗II类主要组织相容性复合体(MHC)单域抗体,在小鼠中通过PET检测异位胰腺肿瘤来证明该方法的实用性。我们将宏观PET图像与肿瘤的微观双光子可视化相关联。我们的方法以补充传统F-FDG成像的分子特异性水平,提供了轻松获得F标记抗体及其片段的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfc/4827674/07880df9f304/oc-2015-00121j_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfc/4827674/7ff04ff5cbde/oc-2015-00121j_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfc/4827674/cee45d49c093/oc-2015-00121j_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfc/4827674/07880df9f304/oc-2015-00121j_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfc/4827674/7ff04ff5cbde/oc-2015-00121j_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfc/4827674/cee45d49c093/oc-2015-00121j_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfc/4827674/07880df9f304/oc-2015-00121j_0004.jpg

相似文献

1
The use of F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.使用F-2-氟脱氧葡萄糖(FDG)标记抗体片段用于胰腺癌的免疫正电子发射断层显像(immuno-PET)。
ACS Cent Sci. 2015 Jun 24;1(3):142-147. doi: 10.1021/acscentsci.5b00121. Epub 2015 Jun 3.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.新型氟-18 标记 TCO 类似物用于前靶向 PET 成像的稳定性提高。
Nucl Med Biol. 2019 Sep-Oct;76-77:36-42. doi: 10.1016/j.nucmedbio.2019.11.001. Epub 2019 Nov 5.
4
A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for F-Immuno-PET and Fluorescence Imaging.一种双模态连接子实现了抗体片段的定点偶联,用于 F-免疫 PET 和荧光成像。
J Nucl Med. 2019 Oct;60(10):1467-1473. doi: 10.2967/jnumed.118.223560. Epub 2019 Mar 15.
5
An Efficient Method for Labeling Single Domain Antibody Fragments with F Using Tetrazine- Trans-Cyclooctene Ligation and a Renal Brush Border Enzyme-Cleavable Linker.一种使用四嗪-反式环辛烯连接和肾脏刷状缘酶可切割接头对单域抗体片段 F 进行标记的有效方法。
Bioconjug Chem. 2018 Dec 19;29(12):4090-4103. doi: 10.1021/acs.bioconjchem.8b00699. Epub 2018 Nov 14.
6
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.胰腺癌的预靶向免疫正电子发射断层显像:克服循环抗原和内化抗体以降低辐射剂量
J Nucl Med. 2016 Mar;57(3):453-9. doi: 10.2967/jnumed.115.163824. Epub 2015 Oct 15.
7
Improved metabolic stability for 18F PET probes rapidly constructed via tetrazine trans-cyclooctene ligation.通过四嗪-反式环辛烯连接快速构建的18F PET探针的代谢稳定性得到改善。
Bioconjug Chem. 2015 Mar 18;26(3):435-42. doi: 10.1021/acs.bioconjchem.5b00089. Epub 2015 Mar 4.
8
Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumors.用 [(18)F]AlF 标记的抗 CEA 抗体片段用于 CEA 表达肿瘤的 PET 成像。
Bioconjug Chem. 2014 Feb 19;25(2):335-41. doi: 10.1021/bc4004926. Epub 2014 Jan 8.
9
(18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.(18)F-FPPRGD2 PET/CT:乳腺癌患者的初步评估阶段。
Radiology. 2014 Nov;273(2):549-59. doi: 10.1148/radiol.14140028. Epub 2014 Jul 16.
10
Quantitative imaging characteristics of zirconium-89 on Gemini Time-Of-Flight PET/CT.锆-89在双子座飞行时间PET/CT上的定量成像特征
Nucl Med Commun. 2016 Dec;37(12):1238-1245. doi: 10.1097/MNM.0000000000000602.

引用本文的文献

1
PET imaging of HIV-1 envelope protein gp120 using F-labeled nanobodies.使用氟标记纳米抗体对HIV-1包膜蛋白gp120进行正电子发射断层显像(PET)成像。
iScience. 2025 Jan 13;28(2):111795. doi: 10.1016/j.isci.2025.111795. eCollection 2025 Feb 21.
2
Advancements in nuclear imaging using radiolabeled nanobody tracers to support cancer immunotherapy.使用放射性标记纳米抗体示踪剂的核成像技术进展,以支持癌症免疫治疗。
Immunother Adv. 2024 Aug 26;4(1):ltae006. doi: 10.1093/immadv/ltae006. eCollection 2024.
3
Claudin18.2-Targeted SPECT/CT Imaging for Gastric Cancer: Preclinical Evaluation and Clinical Translation of the Tc-Labeled Nanobody (PHG102) Radiotracer.

本文引用的文献

1
Noninvasive imaging of immune responses.免疫反应的非侵入性成像
Proc Natl Acad Sci U S A. 2015 May 12;112(19):6146-51. doi: 10.1073/pnas.1502609112. Epub 2015 Apr 20.
2
Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody.用¹⁷⁷Lu标记的抗HER2纳米抗体进行靶向放射性核素治疗。
Theranostics. 2014 Apr 25;4(7):708-20. doi: 10.7150/thno.8156. eCollection 2014.
3
Nanobody-based products as research and diagnostic tools.基于纳米抗体的产品作为研究和诊断工具。
Claudin18.2靶向的SPECT/CT成像用于胃癌:锝标记纳米抗体(PHG102)放射性示踪剂的临床前评估与临床转化
ACS Pharmacol Transl Sci. 2024 Jul 20;7(8):2465-2475. doi: 10.1021/acsptsci.4c00280. eCollection 2024 Aug 9.
4
Synthetic F labeled biomolecules that are selective and promising for PET imaging: major advances and applications.用于正电子发射断层扫描(PET)成像具有选择性且前景广阔的合成F标记生物分子:主要进展与应用
RSC Med Chem. 2024 Apr 17;15(6):1899-1920. doi: 10.1039/d4md00033a. eCollection 2024 Jun 19.
5
Development of a Stable Peptide-Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry.通过分选酶和点击化学法开发稳定的肽-主要组织相容性复合体(MHC)
ACS Pharmacol Transl Sci. 2024 May 24;7(6):1746-1757. doi: 10.1021/acsptsci.3c00268. eCollection 2024 Jun 14.
6
The Future of TCR-like Antibodies in Diagnosis and Potential Application Targets.TCR 样抗体在诊断中的未来及潜在应用靶点
Curr Mol Med. 2025;25(6):672-685. doi: 10.2174/0115665240297179240514030532.
7
Nanobody-based CAR NK cells for possible immunotherapy of MICA tumors.基于纳米抗体的嵌合抗原受体自然杀伤细胞用于MICA肿瘤的潜在免疫治疗。
PNAS Nexus. 2024 May 6;3(5):pgae184. doi: 10.1093/pnasnexus/pgae184. eCollection 2024 May.
8
MICA-specific nanobodies for diagnosis and immunotherapy of MICA tumors.用于 MICA 肿瘤诊断和免疫治疗的 MICA 特异性纳米抗体。
Front Immunol. 2024 Mar 14;15:1368586. doi: 10.3389/fimmu.2024.1368586. eCollection 2024.
9
Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of -Cyclooctene-Functionalized Molecular Spherical Nucleic Acids.用于预靶向正电子发射断层扫描成像的四嗪糖缀合物,用于环辛烯功能化分子球形核酸的成像。
ACS Omega. 2023 Nov 24;8(48):45326-45336. doi: 10.1021/acsomega.3c04041. eCollection 2023 Dec 5.
10
Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics.小抗体,大应用:基于纳米抗体的癌症诊断与治疗
Cancers (Basel). 2023 Nov 29;15(23):5639. doi: 10.3390/cancers15235639.
Trends Biotechnol. 2014 May;32(5):263-70. doi: 10.1016/j.tibtech.2014.03.001. Epub 2014 Apr 1.
4
Nanobody: the "magic bullet" for molecular imaging?纳米抗体:分子成像的“神奇子弹”?
Theranostics. 2014 Jan 29;4(4):386-98. doi: 10.7150/thno.8006. eCollection 2014.
5
Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody.用 89Zr-和 124I 标记的抗 PSCA A11 迷你抗体对前列腺癌异种移植进行定量免疫 PET 研究。
J Nucl Med. 2014 Mar;55(3):452-9. doi: 10.2967/jnumed.113.120873. Epub 2014 Feb 6.
6
Enhanced catalysis of oxime-based bioconjugations by substituted anilines.取代苯胺对肟基生物共轭反应的催化作用增强。
Bioconjug Chem. 2014 Jan 15;25(1):93-101. doi: 10.1021/bc400380f. Epub 2013 Dec 17.
7
Site-specific C-terminal and internal loop labeling of proteins using sortase-mediated reactions.利用 sortase 介导的反应进行蛋白质的定点 C 末端和内部环标记。
Nat Protoc. 2013 Sep;8(9):1787-99. doi: 10.1038/nprot.2013.101. Epub 2013 Aug 29.
8
Enzymatic labeling of proteins: techniques and approaches.酶标记蛋白质:技术与方法。
Bioconjug Chem. 2013 Aug 21;24(8):1277-94. doi: 10.1021/bc400102w.
9
A highly efficient catalyst for oxime ligation and hydrazone-oxime exchange suitable for bioconjugation.一种高效的肟连接和腙肟交换催化剂,适用于生物偶联。
Bioconjug Chem. 2013 Mar 20;24(3):333-42. doi: 10.1021/bc3004167. Epub 2013 Mar 6.
10
The pancreas cancer microenvironment.胰腺癌微环境。
Clin Cancer Res. 2012 Aug 15;18(16):4266-76. doi: 10.1158/1078-0432.CCR-11-3114.